Daphne A. Haas‐Kogan

Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors

Ingo K. Mellinghoff, Maria Y. Wang, Igor Vivanco et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text

Medicine, Molecular Medicine, Oncology +16

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-<i>cis</i>-Retinoic Acid: A Children's Oncology Group Study

Katherine K. Matthay, C. Patrick Reynolds, Robert C. Seeger et al. · Journal of Clinical Oncology · 2009 · 856 citations

Medicine, Oncology, Chemotherapy +6

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study

Daniel Cagney, Allison Martin, Paul J. Catalano et al. · Neuro-Oncology · 2017 · 838 citations · Full text

Medicine, Biostatistics, Oncology +10

Loss of <i>PTEN</i> facilitates HIF-1-mediated gene expression

Wayne Zundel, Cornelia Schindler, Daphne A. Haas‐Kogan et al. · Genes & Development · 2000 · 833 citations · Full text

Medicine, Cancer Biology, Oncology +17

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 702 citations · Full text

Medicine, Molecular Genetics, Oncology +12